BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16957915)

  • 1. Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.
    Kishikawa N; Hamachi C; Imamura Y; Ohba Y; Nakashima K; Tagawa Y; Kuroda N
    Anal Bioanal Chem; 2006 Oct; 386(3):719-24. PubMed ID: 16957915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precolumn fluorescence labeling method for simultaneous determination of hydroxyzine and cetirizine in human serum.
    Hammad SF; Mabrouk MM; Habib A; Elfatatry H; Kishikawa N; Nakashima K; Kuroda N
    Biomed Chromatogr; 2007 Oct; 21(10):1030-5. PubMed ID: 17516468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxyoxalate chemiluminescence detection for the highly sensitive determination of fluorescence-labeled chlorpheniramine with Suzuki coupling reaction.
    Adutwum LA; Kishikawa N; Ohyama K; Harada S; Nakashima K; Kuroda N
    Anal Bioanal Chem; 2010 Sep; 398(2):823-9. PubMed ID: 20582691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace analysis of haloperidol and its chiral metabolite in plasma by capillary electrophoresis.
    Wu SM; Ko WK; Wu HL; Chen SH
    J Chromatogr A; 1999 Jun; 846(1-2):239-43. PubMed ID: 10420615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography.
    Yasui-Furukori N; Inoue Y; Chiba M; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(1):175-80. PubMed ID: 15113555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
    Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
    J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography-mass spectrometry with electrospray ionization.
    Hoja H; Marquet P; Verneuil B; Lotfi H; Dupuy JL; Pénicaut B; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):275-80. PubMed ID: 9061465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid determination of haloperidol and its metabolites in human plasma by HPLC using monolithic silica column and solid-phase extraction.
    Aboul-Enein HY; Ali I; Hoenen H
    Biomed Chromatogr; 2006 Aug; 20(8):760-4. PubMed ID: 16261544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection.
    Korpi ER; Phelps BH; Granger H; Chang WH; Linnoila M; Meek JL; Wyatt RJ
    Clin Chem; 1983 Apr; 29(4):624-8. PubMed ID: 6831688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Igarashi K; Castagnoli N
    J Chromatogr; 1992 Sep; 579(2):277-83. PubMed ID: 1429975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence labeling method for aryl halides with 4-(4,5-diphenyl-1H-imidazol-2-yl)phenylboronic acid based on Suzuki coupling reaction.
    Kuroda N; Sugihara S; Sugihara Y; Wada M; Kishikawa N; Ohba Y; Nakashima K
    J Chromatogr A; 2005 Feb; 1066(1-2):119-25. PubMed ID: 15794562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved sensitive assay for simultaneous determination of plasma haloperidol and reduced haloperidol levels by liquid chromatography using a coulometric detector.
    Hariharan M; Kindt EK; VanNoord T; Tandon R
    Ther Drug Monit; 1989 Nov; 11(6):701-7. PubMed ID: 2595753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the antipsychotics flupentixol and haloperidol in human serum by high-performance liquid chromatography with ultraviolet detection.
    Walter S; Bauer S; Roots I; Brockmöller J
    J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):231-7. PubMed ID: 9892087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring haloperidol exposure in body fluids and hair of children by liquid chromatography-high-resolution mass spectrometry.
    Favretto D; Stocchero G; Nalesso A; Vogliardi S; Boscolo-Berto R; Montisci M; Ferrara SD
    Ther Drug Monit; 2013 Aug; 35(4):493-501. PubMed ID: 23851906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of eight schizophrenics.
    Ulrich S; Meyer FP; Neuhof S; Knorr W
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):289-96. PubMed ID: 7735476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms.
    Eyles DW; Stedman TJ; Pond SM
    Psychopharmacology (Berl); 1994 Oct; 116(2):161-6. PubMed ID: 7862945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma assay of haloperidol by high performance liquid chromatography].
    Hequet D; Jarry C; Rouquette C; Brachet-Liermain A
    Ann Biol Clin (Paris); 1985; 43(5):739-42. PubMed ID: 4091320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of MDMA and MDA in abusers' hair samples by semi-micro column HPLC with fluorescence detection.
    Nakamura S; Tomita M; Wada M; Chung H; Kuroda N; Nakashima K
    Biomed Chromatogr; 2006; 20(6-7):622-7. PubMed ID: 16779783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.
    Aravagiri M; Marder SR; Van Putten T; Marshall BD
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):373-81. PubMed ID: 7987490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.